Welcome to our dedicated page for Ashland news (Ticker: ASH), a resource for investors and traders seeking the latest updates and insights on Ashland stock.
Ashland Inc. (NYSE: ASH) is a premier global specialty chemicals company that serves a wide range of consumer and industrial markets. With a workforce of nearly 7,000 passionate professionals, including renowned scientists, research chemists, talented engineers, and plant operators, Ashland thrives on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries.
Operating in four distinct segments—Life Sciences, Personal Care, Specialty Additives, and Intermediates—Ashland is a key supplier to pharmaceutical companies, manufacturers of personal care products, food and beverages, nutraceuticals, and supplements. The Life Sciences segment generates the highest revenue, reflecting the company’s strong focus on this area.
Recently, Ashland announced significant organizational changes within its finance, strategy, mergers and acquisitions (M&A), and portfolio teams. The company has also issued its first-quarter financial results for fiscal year 2024 and outlined its outlook for the second quarter and full year. Ashland's leadership positions in high-quality, consumer-focused markets such as pharmaceuticals, personal care, and architectural coatings underline its commitment to excellence.
Ashland continues to foster gender equity and empowerment by spotlighting inspirational female employees, particularly in recognition of International Women’s Day. The company recently increased its support for greenlight4girls, a global initiative to inspire girls in STEM fields.
In line with its strategic goals, Ashland has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC. The transaction, expected to close in the third quarter of 2024, is subject to customary closing conditions.
For the latest updates and more detailed information, visit the official Ashland website and the Investor Relations section.
Ashland Global Holdings Inc. (NYSE: ASH) will announce its first-quarter earnings on February 3, 2021, at 5 p.m. ET, followed by a live webcast on February 4, 2021, at 9 a.m. ET. The event will feature insights from key executives, including CEO Guillermo Novo and CFO Kevin Willis. An executive summary and detailed remarks will be part of the presentation. Archived materials will be available on the investor relations website for 12 months.
Ashland Global Holdings Inc. (NYSE: ASH) announced a definitive agreement to acquire the personal care business from Schülke & Mayr GmbH for €262.5 million in an all-cash deal. The acquisition, expected to close by the end of the June quarter, aims to enhance Ashland's position in specialty additives and expand its biotechnology and microbiology capabilities. This transaction is anticipated to be immediately accretive to earnings per share, aligning with Ashland's ESG goals and the 'clean beauty' trend in personal care.
On November 18, 2020, Ashland Global Holdings Inc. (NYSE: ASH) announced a quarterly cash dividend of $0.275 per share. This dividend will be payable on December 15, 2020, to stockholders recorded by December 1, 2020. With 60,578,546 shares outstanding as of October 31, 2020, the declaration reflects the company's commitment to returning value to its shareholders while continuing its operations across various consumer and industrial markets globally.
Ashland Global Holdings Inc. (NYSE: ASH) reported preliminary results for Q4 FY2020, with sales of $609 million, unchanged year-over-year but up 6% sequentially. Net income fell to $5 million or $0.07 per diluted share, down significantly from $411 million in the prior year. However, adjusted income from continuing operations increased to $76 million, or $1.25 per diluted share, reflecting a strong adjusted EBITDA of $154 million. Cash flows from operations reached $160 million, leading to free cash flows of $116 million.
Ashland Global Holdings Inc. (NYSE: ASH) announced plans to release its fourth-quarter earnings on November 10, 2020, at 5 p.m. ET. A live webcast with analysts and investors will occur on November 11, 2020, at 9 a.m. ET, featuring an executive summary and detailed remarks. Key executives participating include CEO Guillermo Novo and CFO Kevin Willis. Supporting materials will be available on the Investor Relations section of Ashland's website. The archived webcast will remain accessible for 12 months.
The board of directors of Ashland Global Holdings has declared a quarterly cash dividend of $0.275 per share on its common stock. This dividend is payable on September 15, 2020, to stockholders on record by September 1, 2020. As of July 31, 2020, Ashland had 60,542,901 shares of common stock outstanding, reflecting a commitment to return value to its shareholders. Ashland operates as a global specialty chemicals company, providing solutions across diverse markets.
Ashland Global Holdings Inc. reported Q3 2020 sales of $574 million, a 10% decline year-over-year. Net income was $37 million, or $0.61 per diluted share, down from $66 million the previous year. Income from continuing operations rose to $50 million from $23 million, while adjusted EBITDA increased by 2% to $143 million. The consumer segment performed well with a 1% decline in sales, while the industrial segment saw a 23% drop. Ashland aims for $40 million in cost savings by fiscal year-end.
Ashland Global Holdings Inc. (NYSE: ASH) has announced an agreement to sell its maleic anhydride business and manufacturing facility in Neal, West Virginia, to AOC Materials LLC for $100 million. The deal is expected to close by the end of 2020, pending regulatory approvals. This sale aligns with Ashland's strategy to streamline its portfolio and focus on specialty ingredients and improved margins. AOC expresses excitement over the growth potential of the acquired business, which serves applications in coatings and polymers.
Ashland Global Holdings Inc. (NYSE: ASH) released preliminary financial results for the third quarter of fiscal 2020, reporting sales of approximately $574 million, a 10% decrease year-over-year. Income from continuing operations is expected to be around $50 million, equating to $0.81 per diluted share. Adjusted EBITDA is projected at $143 million, reflecting a 2% growth. The company noted strong demand in consumer markets, particularly in pharmaceuticals and sanitizers, while industrial demand weakened. Ashland aims to further enhance its cost structure, anticipating $20-$30 million in cost reductions.
FAQ
What is the current stock price of Ashland (ASH)?
What is the market cap of Ashland (ASH)?
What does Ashland Inc. specialize in?
How many employees does Ashland Inc. have?
What are the main business segments of Ashland Inc.?
Who are some of Ashland Inc.'s key customers?
What recent organizational changes has Ashland Inc. announced?
How does Ashland Inc. support gender equity?
What strategic transaction did Ashland Inc. recently announce?
Where can I find Ashland Inc.'s financial updates?
What is Ashland Inc.'s ticker symbol and where is it listed?
What are some key markets served by Ashland Inc.?
